Streetbeat News

COOT

Australian Oilseeds Holdings Limited

Open

0.92

Mkt cap

21M

Volume

High

0.93

P/E Ratio

23.00

52-wk high

11.96

Low

0.85

Div yield

N/A

52-wk low

0.61

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares surged 31.4% in pre-market trading following a narrower Q4 net loss compared to the previous year. Other stocks also showed significant movement in pre-market trading, with notable gainers including Next.e.GO N.V. (NASDAQ:EGOX) and MicroAlgo Inc. (NASDAQ:MLGO), and losers such as Sintx Technologies, Inc. (NASDAQ:SINT) and Invivyd, Inc. (NASDAQ:IVVD).

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:03 pm

Shares of Australian Oilseeds (COOT) were halted due to a circuit breaker being triggered. This action typically occurs when there's a significant price movement, indicating either a sharp increase or decrease in the stock's value.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:47 pm

Australian Oilseeds, identified by the ticker COOT, has officially opened its shares for trade following its initial public offering (IPO). This marks a significant milestone for the company as it transitions into a publicly traded entity on the US stock market.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:46 pm

Trading for COOT was halted and then resumed at 9:40 AM ET due to the availability of a new issue.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 1:40 pm

Australian Oilseeds, a leading cold-processing oil giant in the APAC region, is set to debut on Nasdaq under the ticker 'COOT'. Over the past 20 years, AOI has become the largest cold pressing oil plant in the APAC, focusing on GMO-free conventional and organic oilseeds. The company is expanding its operations by enhancing its existing plant and constructing a new multi-seed crushing plant in Queensland, aiming to become the largest cold-pressed producer in the Oceanic/APAC region.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:18 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.